RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032

Overview

The RoMEA Human Leukocyte Antigen Typing For Transplant Market is expected to reach a 14.73 USD Million by 2032 and is projected to grow at a CAGR of 6.49% from 2025 to 2032.

Revenue, 2024 (USD Million)
10.19
Forecast, 2032 (USD Million)
14.73
CAGR, 2024 - 2032
6.49%
Report Coverage
RoMEA

RoMEA Human Leukocyte Antigen Typing For Transplant Market 2018-2032 USD Million

RoMEA Human Leukocyte Antigen Typing For Transplant Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 10.19 USD Million
  • Projected Market Size (2032): 14.73 USD Million
  • CAGR (2025-2032): 6.49%

Key Findings of RoMEA Human Leukocyte Antigen Typing For Transplant Market

  • The RoMEA Human Leukocyte Antigen Typing For Transplant Market was valued at 10.19 USD Million in 2024.
  • The RoMEA Human Leukocyte Antigen Typing For Transplant Market is likely to grow at a CAGR of 6.49% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Molecular Assay Technologies in Technology Segment accounted for the largest share of the market with a revenue of 7.92 USD Million
  • The fastest growing segment Hospitals & Transplant Centers in End Users Segment grew Fastest with a CAGR of 8.05% during the forecast period from 2024 to 2032.

RoMEA Human Leukocyte Antigen Typing For Transplant Market Scope

RoMEA Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
Technology
  • Non-Molecular Assay Technologies
  • Molecular Assay Technologies
Products & Services
  • Software & Services
  • Reagents and Consumables
  • Instruments
End Users
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Hospitals & Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Hematopoietic Stem Cell Transplant
  • Solid Organ Transplant

RoMEA Human Leukocyte Antigen Typing For Transplant Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 10.19 USD Million
Market Value in 2032 14.73 USD Million
CAGR (2025-2032) 6.49%
Historic Data 2016-2023
Market Segments Covered Technology,Products & Services,End Users,Application,Transplant Type

Regional Insights:

  • Leading Market (2024-2032): RoMEA, leading in terms of revenue 10.19 USD Million in 2024
    • Key Country: RoMEA, leading in terms of revenue with value of 10.19 USD Million in 2024.

Segments and Scope

  • RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032, By Technology
    • Molecular Assay Technologies is the largest segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 7.92 USD Million in the year 2024.
    • Molecular Assay Technologies is the Fastest growing segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 7.13 % in forecast period 2025-2032.
  • RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032, By Products & Services
    • Instruments is the largest segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 4.90 USD Million in the year 2024.
    • Reagents and Consumables is the Fastest growing segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 5.48 % in forecast period 2025-2032.
  • RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032, By End Users
    • Hospitals & Transplant Centers is the largest segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 5.01 USD Million in the year 2024.
    • Hospitals & Transplant Centers is the Fastest growing segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 8.05 % in forecast period 2025-2032.
  • RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032, By Application
    • Diagnostic Applications is the largest segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 6.51 USD Million in the year 2024.
    • Diagnostic Applications is the Fastest growing segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 7.10 % in forecast period 2025-2032.
  • RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032, By Transplant Type
    • Solid Organ Transplant is the largest segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 6.35 USD Million in the year 2024.
    • Solid Organ Transplant is the Fastest growing segment in RoMEA Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 7.14 % in forecast period 2025-2032.

RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Share Analysis

 
Company Name Company Share Analysis
Membrane Solutions, LLC.
Porex
SARTORIUS AG
RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Share Analysis

RoMEA Human Leukocyte Antigen Typing For Transplant Market Geographical Sales Distribution, 2018-2032 USD Million

RoMEA Human Leukocyte Antigen Typing For Transplant Market Geographical Sales Distribution, 2018-2032 USD Million

RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Profiling

RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Frequently Asked Questions
The RoMEA Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
RoMEA Human Leukocyte Antigen Typing For Transplant Market was valued at USD 10.19(Revenue in USD Million) in 2020.
RoMEA Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 6.49% during the forecast period of 2024 to 2032.
The Molecular Assay Technologies segment is expected to dominate the RoMEA Human Leukocyte Antigen Typing For Transplant Market, holding a largest market share of 7.92 USD Million in 2024

Coming Soon....

RoMEA Human Leukocyte Antigen Typing For Transplant Market Scope

RoMEA Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
Technology
  • Non-Molecular Assay Technologies
  • Molecular Assay Technologies
Products & Services
  • Software & Services
  • Reagents and Consumables
  • Instruments
End Users
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Hospitals & Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Hematopoietic Stem Cell Transplant
  • Solid Organ Transplant
Frequently Asked Questions
The RoMEA Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
RoMEA Human Leukocyte Antigen Typing For Transplant Market was valued at USD 10.19(Revenue in USD Million) in 2020.
RoMEA Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 6.49% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Human Leukocyte Antigen Typing For Transplant Market for final year is USD 14.73 (USD Million).

RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Profiling

RoMEA Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Frequently Asked Questions
The RoMEA Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
RoMEA Human Leukocyte Antigen Typing For Transplant Market was valued at USD 10.19(Revenue in USD Million) in 2020.
RoMEA Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 6.49% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Human Leukocyte Antigen Typing For Transplant Market for final year is USD 14.73 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.